US2008213338A1PendingUtilityA1
Implant stent with a retinoid for improved biocompatibility
Est. expiryAug 11, 2017(expired)· nominal 20-yr term from priority
A61K 9/0051A61L 2300/45A61K 31/455A61L 27/54A61K 31/07A61L 2300/428A61L 2300/602A61L 27/18
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An implant device is provided which incorporates a retinoid for improving the biocompatibility of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a permanent implant which includes a surface treated with a retinoid for increasing the biocompatibility thereof.
Claims
exact text as granted — not AI-modified1 . In an endovascular stent implantable in a blood vessel and incorporating a therapeutic agent an improvement comprising a retinoid, separate from said therapeutic agent, for improving biocompatibility of the stent in said blood vessel.
2 . The improvement according to claim 1 wherein said retinoid is coated on the stent.
3 . The improvement according to claim 1 wherein said retinoid is bonded to the stent.
4 . The device according to claim 1 wherein said retinoid comprises a retinoid receptor agonist.
5 . The device according to claim 1 wherein said therapeutic agent, stent and retinoid are homogeneous.
6 . The device according to claim 4 wherein said retinoid receptor agonist comprises a naturally occurring retinoid.
7 . The device according to claim 4 wherein said retinoid receptor agonist is selected from a group consisting of Vitamin A (retinal), Vitamin A aldehyde (retinal), Vitamin A acid (retinoic acid) and their synthetic and natural congeners.
8 . The device according to claim 4 wherein the retinoid receptor agonist comprises ethyl-6-[2-(4,4-dimethylthiochroman-6yl)ethyl]nicotinate.
9 . The device according to claim 4 wherein retinoid receptor comprises 6-[2-(4,4-dimethylchroman-6-yl)ethynyl]nicotinic acid.
10 . The device according to claim 4 wherein the retinoid receptor agonist comprises p-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2naphthyl)propenyl]-benzoic acid.Join the waitlist — get patent alerts
Track US2008213338A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.